The Ubc9 SUMO-conjugating enzyme and the Siz1 SUMO ligase sumoylate several repair and recombination proteins, including PCNA. Sumoylated PCNA binds Srs2, a helicase counteracting certain recombination events. Here we show that ubc9 mutants depend on checkpoint, recombination, and replication genes for growth. ubc9 cells maintain stalled-fork stability but exhibit a Rad51-dependent accumulation of cruciform structures during replication of damaged templates. Mutations in the Mms21 SUMO ligase resemble the ubc9 mutations. However, siz1, srs2, or pcna mutants altered in sumoylation do not exhibit the ubc9/mms21 phenotype. Like ubc9/mms21 mutants, sgs1 and top3 mutants also accumulate X molecules at damaged forks, and Sgs1/BLM is sumoylated. We propose that Ubc9 and Mms21 act in concert with Sgs1 to resolve the X structures formed during replication. Our results indicate that Ubc9-and Mms21-mediated sumoylation functions as a regulatory mechanism, different from that of replication checkpoints, to prevent pathological accumulation of cruciform structures at damaged forks.
INTRODUCTION
Unscheduled recombination events during S phase may lead to chromosomal rearrangements, which are associated with human diseases and cancer. The replication process is often fraught with danger, as DNA lesions, defective replication proteins, or limited deoxyribonucleotide pools (dNTPs) can impede replication-fork progression. Stalled forks are potentially unstable and, when unprotected, can collapse, rearrange, or break (Branzei and Foiani, 2005) . Increasing evidence suggests that broken forks can undergo aberrant recombination events to form unstable chromosomal translocations. The replication checkpoint controls stalled fork stability (Boddy and Russell, 2001; Lopes et al., 2001; Sogo et al., 2002; Tercero and Diffley, 2001 ) and replisome-fork association Lucca et al., 2004) , thus preventing the pathological formation of recombinogenic structures such as reversed forks and hemireplicated DNA regions.
Forks encountering lesions on the template experience continuous rounds of pausing and restart. The mechanisms that regulate fork restart under these conditions are less well understood. Several studies have implicated the RecQ-family helicases, which include Sgs1 in budding yeast, Rqh1 in fission yeast, and BLM and WRN syndrome helicases in human, in facilitating the resumption of DNA synthesis at sites of replication-fork breakdown or dealing with homologous recombination events (Khakhar et al., 2003) . However, unlike replication-checkpoint mutants, sgs1 cells do not accumulate pathological structures when forks stall in response to hydroxyurea treatment but rather accumulate structures resembling pseudodouble Holliday junctions or hemicatenane-like molecules, specifically when forks encounter a damaged template (Liberi et al., 2005) . The sgs1 defect is consistent with the in vitro finding that the BLM/Top3 complex dissolves hemicatenane-like structures (Wu and Hickson, 2003) . These results suggest that the replication checkpoint and RecQ helicases cooperate to allow fork resumption. Sgs1 (Wohlschlegel et al., 2004) as well as WRN and BLM (Eladad et al., 2005; Kawabe et al., 2000) is modified with SUMO, and the BLM function in DNA repair and localization to repair foci is modulated by this modification (Eladad et al., 2005) .
Sumoylation is a multistep process mediated by E1, E2, and E3 enzymes (Johnson, 2004) . Sumoylation relies on a single E2 conjugating enzyme, Ubc9, encoded by a highly conserved, essential gene. Three E3 SUMO ligases, Siz1, Siz2, and Mms21, have been identified so far in budding yeast and have been shown to promote the sumoylation of different targets. However, different studies indicate that Ubc9 may mediate sumoylation of target proteins alone, without the need for a SUMO ligase (see Mo and Moschos, 2005) . Consistent with this, Ubc9 has been shown to interact with many SUMO substrates in the yeast two-hybrid system. Moreover, crystallographic studies suggest that E3 ligases, in certain cases, interact more with the Ubc9-SUMO complex than the target substrate by optimally fixing the SUMO terminal glycine residue in a favorable orientation to the substrate's target lysine (Reverter and Lima, 2005) . In addition, cells express isopeptidases that are responsible for both SUMO maturation and deconjugation.
Several lines of evidence suggest that Ubc9-mediated sumoylation is involved in maintaining genome integrity. First, the level of expression of UBC9 was found to be increased in several tumor cell lines (Mo and Moschos, 2005) , and inactivating mutations of UBC9 and isopeptidases are lethal in mice (Nacerddine et al., 2005; Yamaguchi et al., 2005) . Second, proteins implicated in preserving genome integrity, such as p53, the RecQ helicases BLM and WRN, PCNA, DNA topoisomerases I and II, Smc1, Smc3, Smc5, and Smc6, have been shown to be SUMO targets (Andrews et al., 2005; Gill, 2004; Johnson, 2004; Potts and Yu, 2005; Zhao and Blobel, 2005) . Third, mutations in budding yeast UBC9 and fission yeast hus5, as well as mutations in the Mms21 SUMO ligase and the Ulp1 and Ulp2 isopeptidases, cause hypersensitivity to DNA-damaging agents and replication inhibitors (al-Khodairy et al., 1995; Hoege et al., 2002; Hochstrasser, 1999, 2000; Maeda et al., 2004; Soustelle et al., 2004; Zhao and Blobel, 2005) . Fourth, the recombination proteins Rad51 and Rad52 interact with SUMO or Ubc9 (Ho et al., 2001; Shen et al., 1996) , and finally, mutations in ULP1 result in a strong hyperrecombination phenotype and synthetic lethality in combination with mutations in genes involved in the homologous recombination pathway (Soustelle et al., 2004) .
Recently, sumoylation has been also implicated in counteracting recombination events during replication (Papouli et al., 2005; Pfander et al., 2005) . In particular, it has been shown that PCNA, once sumoylated through a process dependent on Ubc9 and Siz1, recruits Srs2, a helicase known to disrupt Rad51 filaments and prevent certain recombination events (Krejci et al., 2003; Papouli et al., 2005; Pfander et al., 2005; Veaute et al., 2003) . In a rad18 mutant background context, the recombination events prevented by Srs2 and sumoylated PCNA are thought to promote repair, thus allowing cell survival in response to damage, as shown by the increased resistance of rad18 srs2 or rad18 siz1 cells to DNA-damaging agents (Aboussekhra et al., 1992; Papouli et al., 2005; Pfander et al., 2005; Rong et al., 1991) .
In this report, we examined whether Ubc9-mediated sumoylation is important for replication-fork integrity. We found that ubc9 mutants complete the bulk of DNA replication but accumulate DNA lesions and checkpoint signals; for normal viability, they require a functional replication-checkpoint response and homologous recombination. Replication-fork stability was not dramatically affected in ubc9-1 cells, but replication of damaged templates occurred with pathological accumulation of cruciform structures in a Rad51-dependent manner. This phenotype was also observed in the SUMO ligase mutant mms21, but not in siz1, siz2, or siz1 siz2 mutants deficient in different subpathways of sumoylation. Consistently, the accumulation of X-shaped structures was not seen in mutants defective in PCNA sumoylation. The ubc9/mms21 mutants show a phenotype similar to sgs1 and top3 mutants (Liberi et al., 2005) , and we found that Sgs1 interacts with Ubc9 and is sumoylated. However, the bulk of Sgs1 sumoylation does not depend on Mms21. Our results suggest that Ubc9-and Mms21-mediated sumoylation, together with the Sgs1/Top3 complex, counteracts the accumulation of cruciform intermediates at replication forks during replication resumption processes.
RESULTS
ubc9 Mutants Are Slow Growing in Combination with Mutations in Replication and Homologous Recombination Since the highly conserved Ubc9 SUMO-conjugating enzyme has been implicated in maintaining genome integrity, we used budding yeast as an experimental system to investigate whether Ubc9-mediated sumoylation is important for maintaining the integrity of replication forks. We first analyzed cell survival and cell-cycle progression of ubc9 mutants in the presence of DNA-damaging agents that are known to inhibit DNA replication.
ubc9-1 cells, which carry the Pro69Ser mutation (Seufert et al., 1995) , exhibit temperature sensitivity and hypersensitivity to hydroxyurea (HU) and methyl methanesulfonate (MMS) treatments (data not shown and Hoege et al., 2002; Maeda et al., 2004) . These phenotypes were complemented by the yeast UBC9 (yUBC9) gene and, partially, the mouse UBC9 (mUBC9) gene (data not shown). Previous work showed that, at nonpermissive temperatures, ubc9 mutants arrest with large-budded cells, short preanaphase spindles, and a single nucleus (Seufert et al., 1995) . We found that temperature sensitivity was also associated with increased phosphorylation of the Rad53 kinase, a target of the Mec1 checkpoint kinase ( Figure 1A ), thus suggesting that ubc9-1 cells activate checkpoint signaling. We then tested whether ubc9-1 cells exhibit cellcycle progression defects when released at the nonpermissive temperature (35 C) from a nocodazole-induced G2/M block (see Figure S1 in the Supplemental Data available with this article online). ubc9-1 mutants completed the first two rounds of replication with kinetics similar to wild-type (WT) cells but began to accumulate cells with a 2C DNA content at around 240 min ( Figure S1A ). The status of replication intermediates formed during the first round of replication at 35 C at the ARS305 origin was identical in WT and ubc9 cells ( Figure S1B ) as assayed by 2-dimensional (2D) gel electrophoresis ( Figure S2 ).
Certain mutants defective in DNA replication accumulate chromosomal abnormalities that cause checkpoint activation and a checkpoint-dependent cell-cycle block. Since ubc9 cells accumulate checkpoint signals and exhibit a G2 cell-cycle arrest at high temperatures, we addressed whether the viability of ubc9-1 mutants at permissive temperatures and the cell-cycle arrest at restrictive temperatures were dependent on the Mec1 checkpoint kinase. MEC1 is an essential gene, and its essential function is suppressed by deleting SML1 (Zhao et al., 1998) . Thus, mec1 sml1 cells are viable but checkpoint deficient. We found that the viability of ubc9-1 mutants was severely affected in a sml1 mec1 background ( Figure 1A ). Furthermore, while ubc9-1 mutants progressively accumulated massive DNA damage at restrictive temperatures, causing checkpoint activation and cell-cycle arrest with a 2C DNA content, ubc9-1 sml1 mec1 mutants no longer accumulated in G2 ( Figure 1A ). These results indicate that the problems accumulating in ubc9 cells lead to checkpoint activation, which in turn contributes to cell-cycle delay and is important for viability.
To address which DNA repair pathway (see below) deals with the DNA damage spontaneously arising in ubc9-1 mutants, we analyzed the growth rate and viability of ubc9 -1 rad5, ubc9-1 rad18, ubc9-1 rad1, ubc9-1 rad51, ubc9-1 rad55, ubc9-1 rad59, ubc9-1 mms2, ubc9-1 rad30 , and ubc9-1 rev7 double mutants. Out of these combinations, only the viability of ubc9-1 rad51 and ubc9-1 rad55 was affected at 30 C ( Figure 1B and data not shown). Furthermore, Rad51 (but not Rad18, Rad5, Mms2, Rad30, Rev7, or Rad1) was also required for survival of HU-treated ubc9-1 cells at 25 C (see below and data not shown). Hence, Rad51-dependent homologous recombination is the main repair pathway important for survival of ubc9-1 cells under normal growth conditions or in response to HU-treatment.
In addition, we found that ubc9-1cells exhibited synthetic growth defects at 30 C when combined with deletions in the POL32 gene, which encodes the third subunit of DNA polymerase d and is required for polymerase d processivity (Burgers and Gerik, 1998) . ubc9-1 cells also showed synthetic growth defects with deletions of the RRM3 but not the CHL1 helicase gene. Rrm3 facilitates fork progression in the presence of replication blocks (Ivessa et al., 2002) . Finally, we examined interactions with two helicases implicated in preventing recombination events during S phase (Fabre et al., 2002; Liberi et al., 2005; Rong et al., 1991) . Srs2, which interacts physically and genetically with Pol32 (Huang et al., 2000) was synthetic sick with ubc9-1, and ubc9-1 strains carrying a partial deletion of SGS1 (Onoda et al., 2000) , which disrupts the helicase domain and shows recombination and DNA-damage sensitivity phenotypes similar to sgs1D strains, grew slowly ( Figure 1C and data not shown). Taken together, these results suggest that at least part of the genomic problems arising in ubc9-1 cells result from faulty replication.
ubc9 Mutants Accumulate Cruciform Structures Specifically at Damaged Forks
The finding that no abnormal replication intermediates occurred in ubc9 cells replicating at high temperatures ( Figure S1B ) suggests that the DNA damage accumulating in ubc9 cells is generated gradually. Furthermore, the previous genetic interactions (Figure 1 ) suggest that ubc9 cells experience problems during replication. To understand the nature of these problems, we examined the status of replication intermediates in conditions that specifically induce replication-fork stalling (HU) or intra-S DNA damage (MMS).
We first tested by 2D gel and cell-cycle cytometry whether HU-treated ubc9-1 cells exhibit replication-fork abnormalities and whether they recover properly from an HU block. HU causes a reversible fork arrest, and WT cells were able to resume replication once the HU block was removed. Origin firing generates intermediates that, on 2D gels, migrate as a bubble arc containing forks proceeding bidirectionally, large Y molecules resulting from forks migrating outside of the restriction fragment, and specialized X-shaped sister chromatid junctions (SCJs) resembling hemicatenanes ( Figure S2 ). The kinetics of accumulation of replication intermediates at ARS305 in ubc9-1 and WT cells treated with HU was identical ( Figure 2A ). In addition, FACS analysis of cells released in fresh medium after being blocked in HU showed that ubc9-1 cells completed replication, albeit with a small delay as compared to WT cells, but then accumulated irreversibly in G2 with phosphorylated Rad53 ( Figure 2B and data not shown). By pulsed-field gel electrophoresis (PFGE), we confirmed that, in ubc9 cells recovering from HU, the appearance of the typical chromosomal bands corresponding to fully replicated chromosomes correlated with the completion of S phase observed by FACS analysis (data not shown). The status of replication intermediates and the cell-cycle profiles of ubc9 cells replicating or recovering from HU ( Figure 2 ) suggest that stalled-fork stability is not significantly impaired by the ablation of the Ubc9/SUMO pathway but rather that, in ubc9 cells, the problems might arise at late steps during replication, such as during replication termination or postreplicative repair.
We then analyzed the ability of ubc9 cells to deal with MMS-induced DNA damage; unlike forks encountering HU-induced DNA lesions, forks encountering MMSinduced DNA lesions need to undergo extensive restart to resume replication. By PFGE, we found that, following a transient MMS pulse, ubc9 mutants were delayed in recomposing their chromosomes into sharp bands and accumulated in G2 ( Figure S3 ), thus suggesting that ubc9 cells A) Log phase WT (Y002) and ubc9-1 (Y0174) cells containing YCp-RAD53-HA were shifted for 6 hr at high temperatures, and whole-cell extracts were analyzed by western blot for Rad53 phosphorylation. Strains Y0002 (WT), HY0512 (sml1), HY0514 (sml1 mec1), Y0174 (ubc9-1), HY0513 (ubc9-1 sml1), and HY0515 (ubc9-1 sml1 mec1) were grown in YPD plates for 2 days. Liquid cultures of the same strains were analyzed by FACS.
are defective in recovering from MMS-induced damage. We therefore tested whether the ubc9-1 mutation affects a specific repair pathway ( Figure 3A) . Mutations in genes such as RAD51 and RAD1 increased the MMS sensitivity of ubc9-1 cells, while rev7 and rad30 mutations affected the MMS sensitivity of ubc9-1 only slightly, if at all ( Figure 3B ). We therefore conclude that the MMS sensitivity associated with the ubc9-1 mutation is unlikely to be due primarily to defects in homologous recombination, excision repair, and translesion synthesis pathways. However, we found that the ubc9 (B) Strains Y0002 (WT), Y0174 (ubc9-1), HY0521 (ubc9-1 rad18), HY0517 (ubc9-1 rad5), HY0530 (ubc9-1 rad51), HY0532 (ubc9-1 rad55), HY0534 (ubc9-1 rad59), HY0506 (pol32), and HY0507 (ubc9-1 pol32) were streaked and grown in YPD plates for 2 days; strains Y0002 (WT), Y0174 (ubc9-1), HY0503 (ubc9-1 sgs1), HY0505 (ubc9-1 srs2), HY0509 (ubc9-1 rrm3), and HY0511 (ubc9-1 chl1) were streaked and grown for 3 days. The growth rate of strains HY0521 (ubc9-1 rad18), HY0517 (ubc9-1 rad5), HY0530 (ubc9-1 rad51), HY0532 (ubc9-1 rad55), HY0534 (ubc9-1 rad59), HY0503 (ubc9-1 sgs1), HY0505 (ubc9-1 srs2), HY0509 (ubc9-1 rrm3), and HY0511 (ubc9-1 chl1) was compared to the growth rate of single mutants in independent experiments (data not shown). rad18 mutants are as resistant to MMS treatment as ubc9 cells at both 25 C and 30 C ( Figure 3C ). This is somewhat expected, as in ubc9-1 cells, PCNA is not sumoylated, and pcna-sumo mutants also suppress the rad18 damage sensitivity (Hoege et al., 2002; Papouli et al., 2005; Pfander et al., 2005) . We note that the ubc9-1 mutation suppressed the MMS sensitivity, but not the HU sensitivity, of rad5 and rad18 mutants ( Figure 3C and data not shown). These findings, together with the observation that ubc9 and ubc9 rad18 cells require Rad51 for growth ( Figure 3B and data not shown), suggest that the MMS sensitivity of rad5/ rad18 mutants is alleviated by the ubc9-1 mutation through derepression of recombination. However, it is not clear whether this relief reflects a postreplicative event or whether the Ubc9/SUMO pathway actively functions at damaged replication forks, during DNA synthesis, to prevent recombination.
To address these issues, we analyzed replication forks arising from ARS305 and invading adjacent genomic regions by 2D gels in MMS-treated ubc9-1 and WT cells ( Figure S2 and Figure 4A ). Cells were released from a G2 block in MMS-containing medium. The timing of the appearance of bubbles, large Ys, and SCJs at ARS305 was comparable in the two strains. However, in contrast to WT cells, ubc9-1 mutants accumulated a dramatic amount of X molecules. This abnormal accumulation of X molecules also occurred at those forks invading ARS305-adjacent regions ( Figure 4A and Figure S4 ).
The Abnormal Status of Replication Intermediates of ubc9 Cells Resembles sgs1 Mutants
This ubc9-1 phenotype ( Figure 4A ) is reminiscent of the one observed in MMS-treated sgs1 and top3 mutants (Liberi et al., 2005) . Like ubc9-1 cells, sgs1 cells show normal fork progression in response to HU blocks but accumulate Rad51-dependent cruciform structures upon exposure to MMS (Liberi et al., 2005 ) (see also Figure 5A ). We therefore tested whether the accumulation of X molecules in MMS-treated ubc9-1 cells is dependent on Rad51. In ubc9-1 rad51 cells, the X molecules appeared HY0530 (ubc9-1 rad51) , HY0522 (rad1), HY0523 (ubc9-1 rad1), HY0524 (rad30), HY0525 (ubc9-1 rad5), HY0526 (rev7), and HY0527 (ubc9-1 rev7) strains were grown to log phase and analyzed for MMS and HU sensitivity by spot assay. (C) ubc9-1 suppresses the MMS sensitivity of rad18 strains. The MMS sensitivity of Y0002 (wt), Y0174 (ubc9-1), HY0520 (rad18), and HY0521 (ubc9-1 rad18) strains grown to log phase was assessed by spot assay.
at the same time as in WT cells but, in contrast to ubc9-1 mutants, no longer accumulated at late time points ( Figure 4B ). In addition, the accumulation of cruciform structures in ubc9-1 cells in the regions flanking ARS305 and at ARS301 still required Rad51 ( Figure S4 ). Hence, we conclude that the X molecule accumulation in MMStreated ubc9-1 mutants depends on Rad51. The previous findings (Figure 4) , together with the observation that the accumulation of X molecules is comparable in MMStreated sgs1, ubc9-1, and ubc9-1 sgs1strains ( Figure  5A ), suggest that both Ubc9 and Sgs1 act in counteracting the accumulation of cruciform structures at damaged forks.
The Mms21 SUMO Ligase Counteracts X Molecule Accumulation at Damaged Forks Recently, Siz1-mediated PCNA sumoylation has been implicated in the recruitment of Srs2 to prevent certain recombination events at replicating chromosomes (Papouli et al., 2005; Pfander et al., 2005) . In a rad18 context, the recombination events prevented by Srs2, Siz1, and sumoylated PCNA are likely required to promote repair and important for viability (Aboussekhra et al., 1992; Papouli et al., 2005; Pfander et al., 2005; Rong et al., 1991) . We found that srs2 cells ( Figure S5 and Liberi et al., 2005) ; pol30-RR mutants encoding nonsumoylatable PCNA proteins ( Figure 5B) ; and siz1 mutants ( Figure 6A) , in which the sumoylation of PCNA was previously shown to be ablated (Hoege et al., 2002; Papouli et al., 2005; Pfander et al., 2005) , did not accumulate cruciform structures at the forks when treated with MMS. Thus, we conclude that Srs2 and Siz1-mediated PCNA sumoylation are not critical for preventing the accumulation of cruciform intermediates at damaged forks. Moreover, as the relative accumulation of X molecules in MMS-treated ubc9-1, ubc9-1 srs2 ( Figure S5 ), and ubc9-1 siz1 (data not shown) strains was similar, we can exclude the possibility that, in ubc9-1 cells, an anomalous Srs2 or sumoylated PCNA activity is the primary cause of the cruciform structures that become substrates for Sgs1.
In an attempt to dissect the Ubc9/SUMO pathway further, we tested whether the ablation of any of the known SUMO ligases would cause an accumulation of recombinogenic structures at the forks. We found that, similar to siz1 cells, siz2 mutants did not accumulate cruciform structures at damaged forks; neither did a siz1 siz2 double mutant (data not shown). Thus, we do not observe an accumulation of C, then released in fresh medium containing MMS 0.033% at 30 C, and samples were collected at the indicated time points. DNA samples were cut with HindIII and EcoRV and analyzed using the ARS305 probe.
hemicatenane-like structures at damaged forks in mutants affecting the function of proteins such as PCNA ( Figure 5B ), Top1, Top2, or Pds5 (unpublished data), whose sumoylation is known to be promoted by Siz1 or Siz2 (Stead et al., 2003; Takahashi et al., 2006) . However, like ubc9 cells, mms21 mutants, in which the C-terminal Siz/PIAS domain required for the SUMO ligase activity is disrupted (Andrews et al., 2005; Prakash and Prakash, 1977; Zhao and Blobel, 2005) , accumulate X molecules at damaged replication forks in a Rad51-dependent manner ( Figure 6A and Figure S6) . These results are consistent with findings that mms21 mutants, but not siz1 and siz2 mutants, are sensitive to damaging agents, including MMS (Andrews et al., 2005; Prakash and Prakash, 1977; Zhao and Blobel, 2005) , and that this hypersensitivity requires the SUMO ligase activity of Mms21 (Andrews et al., 2005; Potts and Yu, 2005) . In further support of this idea, we found that the mms21-CH allele, which carries two point mutations (C200A and H202A) affecting the catalytic SUMO ligase activity (Andrews et al., 2005) , also showed accumulation of X molecules at damaged forks ( Figure 6B ). This result suggests that Mms21-mediated sumoylation regulates the process that counteracts cruciform-structure accumulation during DNA replication.
Sgs1 Is Sumoylated, and the Bulk of Sgs1 Sumoylation Does Not Require Mms21
Taking into consideration that BLM/Top3 resolves hemicatenane-like structures (Wu and Hickson, 2003) ; that SGS1 overexpression promotes the resolution of the cruciform intermediates accumulating in MMS-treated sgs1 mutants (Liberi et al., 2005) ; and that X-shaped structures accumulate in MMS-treated sgs1, ubc9, and mms21 cells in a similar manner ( Figure 5A ; Figures 6A and 6B) , it is reasonable to think that Ubc9-and Mms21-mediated sumoylation affects the activity of the Sgs1 complex-either directly, through Sgs1-mediated sumoylation, or indirectly, by means of sumoylation of other targets, which could ultimately affect Sgs1 localization, recruitment, protein interaction, and/or activity. Interestingly, sumoylation of BLM, the human ortholog of Sgs1, has been shown to affect its function in DNA repair and maintenance of genome integrity, likely by modulating BLM recruitment to PML bodies (Eladad et al., 2005) . Furthermore, Sgs1 has been reported to be a SUMO target by a proteomic study using a mass-spectrometry-based approach (Wohlschlegel et al., 2004) . We therefore addressed whether Sgs1 is indeed a SUMO target and whether its sumoylation depends upon Ubc9 and Mms21. We found that Sgs1 interacts with Ubc9 and SUMO in the yeast two-hybrid system and that the interaction with SUMO is dependent on the terminal pair of glycines in yeast SUMO, which are involved in forming thioester bonds with the substrates (Figure 6C ), suggesting that Sgs1 might be sumoylated. Furthermore, we could immunoprecipitate Sgs1 and its SUMO-modified forms from strains having the endogenous Sgs1 tagged at its C terminus with 3HA or 3FLAG ( Figure 6D ). The Sgs1 sumoylation is dependent on Ubc9, as no SUMO-modified forms of Sgs1 were visible in ubc9-1 mutants ( Figure 6D ). Sgs1 sumoylation is increased upon exposure to MMS, but it is not diminished in the mms21 mutation context, under either normal or DNA-damaging conditions ( Figure 6D ). Although we cannot formally rule out, at least at this stage, that certain site-specific sumoylation events depend on Mms21, these results suggest that Mms21 is not responsible for the bulk of Sgs1 sumoylation. However, taking into account the previous results ( Figures 6A and 6B) , the most likely scenario is that Mms21 has other targets, whose sumoylation is important in either promoting or cooperating with Sgs1 in this process.
DISCUSSION
In this study, we analyzed the role of the Ubc9/SUMO pathway in maintaining the integrity of replicating chromosomes. Based on our findings, we can conclude that, during normal chromosome replication, ubc9-1 cells occasionally accumulate lesions that trigger a checkpoint response and require the homologous recombination apparatus for repair. The nature and location of these lesions are still elusive. These events are unlikely to occur at forks in normal regions, as we could not detect any abnormalities at the ARS305 origin in untreated ubc9-1 cells ( Figure S1 ). However, it might be impossible to detect rare events by 2D gel analysis. We also analyzed whether replication of ribosomal DNA (rDNA) regions occurs normally, but we could not detect any significant differences in the status of replication intermediates between ubc9 and WT cells at these loci (data not shown). We provide evidence suggesting that ubc9 mutants experience problems during replication. However, ubc9 cells are not impaired in maintaining the stability of stalled forks in response to HU treatment (Figure 2A ). We confirmed that forks also pause normally in untreated ubc9 cells at genomic locations containing replication-fork barriers and pausing sites such as rDNA and tRNA (data not shown). However, ubc9 cells fail to recover properly from the extensive replication pausing caused by HU treatment ( Figure 2B ) due to the generation of DNA damage and checkpoint signals that cause a cell-cycle block in G2. It is possible that a small proportion of replication forks in ubc9-1 cells fail to efficiently restart during recovery from HU. The synthetic interaction caused by the RRM3 deletion in combination with the ubc9 mutation is consistent with this idea. We envisage that ubc9 cells recovering from HU blocks might occasionally generate DNA breaks due to faulty replicative restart; alternatively, replication of slow zones or certain steps of replication termination might be affected in ubc9 cells ( Figure 7A ).
Our data indicate that Ubc9 controls some crucial steps required for replication of damaged templates. ubc9 mutants accumulate cruciform structures at MMSdamaged forks through a Rad51-dependent process (Figure 4) . This phenotype does not resemble the phenotypes (W303 1-A), siz1 (HY0628), siz2 (HY0634) , and mms21-SP (HY0638) strains (A) were synchronized in G1 with a factor at 25 C, and wild-type (W303 1-A), mms21-11 (FY1012), and mms21-CH (FY1003) strains (B) were synchronized in G2 with nocodazole at 25 C and then released of srs2 (Liberi et al., 2005 ; Figure S5 ), siz1 ( Figure 6A ), or the pcna-sumo mutant pol30-K127R/K164R ( Figure 5B ). These observations suggest that sumoylation of PCNA and its interaction with Srs2 may not be crucial in hindering cruciform structures from accumulating at replication forks in MMS-treated cells or that Srs2, together with sumoylated PCNA, acts at damaged forks either infrequently or transiently, and consequently, its ablation does not result in a large accumulation of X molecules. Instead, our data support the idea that, in response to DNA damage, the Ubc9-and Mms21-dependent sumoylation processes ultimately influence the ability of Sgs1/ Top3 to prevent the accumulation of recombinogenic structures on replicating chromosomes. First, MMStreated ubc9 cells behave like sgs1 and top3 mutants (Figure 4 ; Liberi et al., 2005) . Second, Sgs1/BLM is sumoylated (Eladad et al., 2005; Wohlschlegel et al., 2004; Figures 6C and 6D) . Third, mms21 mutants, which affect a subpathway of sumoylation, behave like ubc9 and sgs1 cells (Figure 4 ; Figure 5A ; Figure 6A and 6B; Figure S6) . Finally, the phenotype of sgs1 appears to be unique among DNA helicases, as mph1 (W. Carotenuto and G.L., unpublished data), srs2, and rrm3 mutants do not show the sgs1 phenotype (data not shown). Our findings that the bulk of Sgs1 sumoylation depends on Ubc9 but not on the Mms21 ligase suggest either that sumoylation is directly mediated by the Ubc9 protein, with which Sgs1 physically interacts ( Figure 6C ), or that another ligase is involved in this process. Furthermore, the results showing that the ability of Mms21 to function as a SUMO ligase is critical for the regulation of X molecule accumulation at damaged forks ( Figures 6A and 6B ) strongly suggest that Mms21 has other targets, whose sumoylation is expected to promote crucial steps in this process such as protein localization, protein-protein interaction, or protein association with DNA. These sumoylation processes may ultimately affect Sgs1 functionality or be required to cooperate with Sgs1 in resolving the hemicatenane-like structures formed during replication ( Figure 7A) . A crucial, although likely not exclusive, target may be the Smc5-6 complex, which is sumoylated by Mms21 and genetically interacts with Sgs1 (Miyabe et al., 2006; Morikawa et al., 2004) . It will be an important future task to determine the Mms21-dependent targets and how they interact or cooperate with Sgs1 and Top3 to allow the resolution of the hemicatenane-like structures, most likely in fresh medium containing MMS 0.033% at 30 C. The DNA from the samples collected at the indicated time points was cut with HindIII and EcoRV and analyzed using the ARS305 probe.
(C) BD-SGS1 in combination with AD-ySUMO, AD-ySUMO-G, AD-yUBC9, and pGAD424 (vector) was transformed in Y190 strains, and the interactions between the proteins fused to the BD and AD domains was assayed by b-gal assay.
(D) Sgs1 is sumoylated. Wild-type (HY0608, HY0661), ubc9-1 (HY0607), mms21-11 (FY1014), and mms21-SP (HY0672) strains containing chromosomal 3HA-or 3FLAG-tagged Sgs1 were grown at 30 C to early log phase, and half of the cultures were treated with MMS 0.3% for 2 hr. The tagged proteins were purified by immunoprecipitation as described in Zhao and Blobel (2005) using anti-HA or anti-FLAG antibodies, respectively. The eluate was analyzed by western blot analysis using anti-SUMO and anti-HA or anti-FLAG antibodies, respectively. formed during damage bypass or gap-filling processes during replication. Based on the characterization of the cruciform structures accumulating at damaged forks through a Rad51-dependent process (Liberi et al., 2005) , it has been hypothesized that these structures represent pseudodouble Holliday junctions in which nascent chains are partially engaged into plectonemic pairings and the corresponding parental tracts into paranemic junctions ( Figure 7A ). This pathological accumulation of hemicatenane-like structures is likely to have tremendous consequences for genomic stability, as their resolution might stimulate recombination and genome rearrangements, and failure to resolve them is expected to affect chromosome condensation, decatenation, and segregation processes. Indeed, both sgs1 and ubc9/mms21/SUMO mutants show defects in these processes (al-Khodairy et al., 1995; Prakash and Prakash, 1977; Watt et al., 1995) , and recently, Ubc9 knockout mice were reported to die at the early postimplantation stage with major chromosome condensation and segregation aberrations (Nacerddine et al., 2005) . We note that the role proposed for Sgs1/Top3 in resolving the hemicatenanes formed by the plectonemic tract is also reminiscent of the process required for the resolution of hemicatenanes when two forks converge at the end of replication ( Figure 7A ). Indeed, Sgs1 and Top3 have been implicated in replication termination (Rothstein and Gangloff, 1995; Wang, 1991) . With this in mind, we speculate that, in addition to the problems encountered following exposure to DNA-damaging agents, some of the genomic problems arising during normal replication in ubc9-1 cells could result from inefficient resolution of hemicatenanes when the replicons fuse together ( Figure 7A ). It is expected that these structures would occasionally give rise to DNA breaks and genomic aberrations and that homologous recombination would have to be involved to solve the termination problem in ubc9 cells. Indeed, recombination is important for viability in ubc9 mutants ( Figure 1B ) and has been already implicated in replication termination (Horiuchi et al., 1994) .
Considering that ubc9 mutants resemble sgs1 cells with regard to their accumulation of cruciform structures; that both the ubc9 and sgs1 phenotypes are complemented by the mammalian UBC9 and BLM genes, respectively; and that BLM and Sgs1 are SUMO targets, it would not be surprising if some BLM variants or other genome-instability disorders result from mutations in genes implicated in the Ubc9/Mms21-mediated SUMO pathway.
In conclusion, this study identifies the Ubc9/Mms21/ SUMO posttranslational modification pathway as a novel regulatory mechanism that prevents cruciform structures from accumulating during replication ( Figure 7B ) and elucidates some of the crucial effectors of this process. Thus, in addition to the roles of the Mec1/Rad53 replication checkpoints (Branzei and Foiani, 2005) , this is the second pathway that opposes the accumulation of recombinogenic structures (and consequently, genome rearrangements) at the forks during DNA synthesis ( Figure 7B ). Interestingly, the mechanisms through which the Mec1/ Rad53 checkpoint and the Ubc9/SUMO pathway act to prevent recombinogenic events during replication are different and can be seen from the outcomes: While the replication checkpoint counteracts fork reversal at stalled forks (Branzei and Foiani, 2005; Lopes et al., 2001; Sogo et al., 2002) , ubc9, mms21, and sgs1/top3 mutants accumulate pseudo-double Holliday junctions resembling hemicatenanes at damaged forks ( Figure 7B ; Liberi et al., 2005) . Thus, cells have evolved at least these two regulatory pathways to counteract the accumulation of recombinogenic structures during replication both when forks stall and when they encounter damaged templates ( Figure 7B ). It will be interesting in the future to determine the effectors of these two pathways that prevent the pathological accumulation of these cruciform structures and whether there is crosstalk between them.
EXPERIMENTAL PROCEDURES

Yeast Strains and Plasmids
The yeast strains used in this study were derivatives of DF5 (Seufert et al., 1995) or W303 (Thomas and Rothstein, 1989) ; the relevant genotypes are shown in Table S1 . Combinations of deletion mutants were constructed using standard yeast techniques . The mms21-SP allele was created by replacing the C-terminal Siz/ PIAS domain of Mms21 with the hphMX4 marker to give a mutation genetically equivalent to that of mms21-11, containing a transposon insertion in the Siz/PIAS domain (Zhao and Blobel, 2005) . For construction of the mms21-CH mutant, the wild-type MMS21 gene was subcloned in pET15B and the C200A and H202A mutations were introduced using the QuikChange Site-Directed Mutagenesis Kit (Stratagene), and the mutations were confirmed by sequencing. The mms21-CH allele was integrated at the chromosomal locus using the method previously described (Reid et al., 2002) . For construction of BD-SGS1, the SGS1 gene was amplified from the genome with oligos containing BamHI and SalI sites and subcloned into pGBD-C3. pGADyUBC9 was described previously (Kawabe et al., 2000) . pGAD-ySUMO contains the yeast SUMO gene, SMT3, subcloned into the SalI site of pGAD424 (a gift from H. Shinagawa). The terminal GG residues of Smt3 were mutated by using the QuikChange Site-Directed Mutagenesis Kit to obtain pGAD-ySUMO-G. The mutant ySUMO protein has G97D, and the G98 is mutated to a stop codon. The mutations were confirmed by sequencing. YCp-RAD53-HA was described previously (Sugimoto et al., 1997) .
Protein Techniques and Antibodies
For western blot analysis, yeast protein extracts were prepared by the TCA method as described previously (Knop et al., 1999) . The antibodies used to detect Rad53 phosphorylation were rabbit anti-HA antibody (MBL) when the YCp-RAD53-HA was used ( Figure 1A ) or monoclonal mouse EL7 antibody (a gift from A. Pellicioli).
The immunoprecipitation and immunoblotting experiments conducted to address the sumoylation of Sgs1, tagged at its C terminus with 3HA or 3FLAG epitope, were performed largely as described in Zhao and Blobel (2005) , except that the antibodies used were 12CA5 (Covance) for HA and the M2 monoclonal antibody (Sigma) for FLAG. Two-Hybrid Assay Y190 cells were transformed with combinations of two plasmids, one containing the SGS1 gene fused to the binding domain (BD) of GAL4 and the other containing one of the indicated genes fused to the activation domain (AD) of the GAL4 protein. The transformants were analyzed for b-galactosidase activity by a filter assay according to the protocol described in the Clontech manual.
Growing Conditions, Cell-Cycle Arrests, Drug Treatments, and Spot Assays Unless otherwise indicated, strains were grown at 25 C in YPD medium containing glucose at 2% w/v. Cell synchronization was performed by adding a factor to a final concentration of 3 mg/ml or nocodazole to a final concentration of 10 mg/ml together with DMSO to a final concentration of 1% v/v for about 2 hr and evaluating the percentage of unbudded (a factor) or large-budded (nocodazole) cells in the culture. The release from a factor was performed as previously described (Liberi et al., 2005) . The release from nocodazole arrest was performed by centrifugation, washing in YPD containing 1% v/v DMSO, and resuspension of cells in fresh medium. The release was performed at 30 C unless otherwise indicated, and MMS and HU were used at final concentrations of 0.033% v/v and 0.2 M, respectively. Analysis of drug sensitivity and growth ability by spot assay was carried out as previously described .
DNA Extraction, 2D Gel Technique, Pulsed-Field Gel Electrophoresis, and Cell-Cycle Analysis Purification of DNA intermediates in the presence of CTAB, 2D gel procedure, and quantification analysis of autoradiograms were carried out as described (Liberi et al., 2005; Lopes et al., 2003) . FACS and chromosome analysis by PFGE analysis were performed as described previously .
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